M C Gillies

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. ncbi Traumatic retinopathy resembling acute macular neuroretinopathy
    M Gillies
    Department of Ophthalmology, Sydney University, New South Wales, Australia
    Aust N Z J Ophthalmol 25:207-10. 1997
  2. ncbi Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial
    Mark C Gillies
    Department of Clinical Ophthalmology, Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
    Clin Experiment Ophthalmol 38:605-12. 2010
  3. ncbi Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial
    Mark C Gillies
    Save Sight Institute, Department of Clinical Ophthalmology, The University of Sydney, Sydney Eye Hospitals, Sydney, NSW, Australia
    Invest Ophthalmol Vis Sci 51:2322-8. 2010
  4. ncbi Familial asymptomatic macular telangiectasia type 2
    Mark C Gillies
    Save Sight Institute, Department of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, Australia
    Ophthalmology 116:2422-9. 2009
  5. ncbi Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema
    Mark C Gillies
    Department of Clinical Ophthalmology and Eye Health, Save Sight Institute, The University of Sydney, Australia
    Ophthalmology 116:2182-7. 2009
  6. ncbi The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration
    Mark C Gillies
    Department of Clinical Ophthalmology, Save Sight Institute, University of Sydney, Sydney, Australia
    Am J Ophthalmol 144:134-6. 2007
  7. ncbi Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema
    Mark C Gillies
    Save Sight and Eye Health Institute, Department of Clinical Ophthalmology, University of Sydney, GPO Box 4337, Sydney NSW 2001, Australia
    Br J Ophthalmol 91:1323-6. 2007
  8. ncbi Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial
    Mark C Gillies
    Save Sight Institute, Department of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, Australia
    Ophthalmology 113:1533-8. 2006
  9. ncbi Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract
    Mark C Gillies
    Save Sight and Eye Health Institute, University of Sydney, NSW, Australia
    Ophthalmology 112:139-43. 2005
  10. ncbi Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial
    Mark C Gillies
    Save Sight Institute, The University of Sydney, Sydney, Australia
    Ophthalmology 118:866-72. 2011

Detail Information

Publications19

  1. ncbi Traumatic retinopathy resembling acute macular neuroretinopathy
    M Gillies
    Department of Ophthalmology, Sydney University, New South Wales, Australia
    Aust N Z J Ophthalmol 25:207-10. 1997
    ..Acute macular neuroretinopathy (AMNR) is an uncommon disease of uncertain aetiology. We report on four males who developed unilateral changes following trauma which closely resembled acute macular retinopathy...
  2. ncbi Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial
    Mark C Gillies
    Department of Clinical Ophthalmology, Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia
    Clin Experiment Ophthalmol 38:605-12. 2010
    ..To describe the 3-year risk of cataract after intravitreal triamcinolone (IVTA) injections for diabetic macular oedema and the outcomes of cataract surgery...
  3. ncbi Pretreatment with intravitreal triamcinolone before laser for diabetic macular edema: 6-month results of a randomized, placebo-controlled trial
    Mark C Gillies
    Save Sight Institute, Department of Clinical Ophthalmology, The University of Sydney, Sydney Eye Hospitals, Sydney, NSW, Australia
    Invest Ophthalmol Vis Sci 51:2322-8. 2010
    ..To determine whether pretreatment with intravitreal triamcinolone acetonide (IVTA) before laser photocoagulation is effective in eyes with diabetic macular edema (DME)...
  4. ncbi Familial asymptomatic macular telangiectasia type 2
    Mark C Gillies
    Save Sight Institute, Department of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, Australia
    Ophthalmology 116:2422-9. 2009
    ..To report findings in asymptomatic family members of patients with macular telangiectasia type 2...
  5. ncbi Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema
    Mark C Gillies
    Department of Clinical Ophthalmology and Eye Health, Save Sight Institute, The University of Sydney, Australia
    Ophthalmology 116:2182-7. 2009
    ..To report 5-year outcomes from a clinical trial of intravitreal triamcinolone acetonide (IVTA) in eyes with diabetic macular edema (DME) and impaired vision despite previous laser treatment...
  6. ncbi The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration
    Mark C Gillies
    Department of Clinical Ophthalmology, Save Sight Institute, University of Sydney, Sydney, Australia
    Am J Ophthalmol 144:134-6. 2007
    ..To evaluate the effect of a single intravitreal injection of triamcinolone (IVTA) on central macular thickness and visual acuity in eyes with minimally classic exudative age-related macular degeneration (AMD)...
  7. ncbi Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedema
    Mark C Gillies
    Save Sight and Eye Health Institute, Department of Clinical Ophthalmology, University of Sydney, GPO Box 4337, Sydney NSW 2001, Australia
    Br J Ophthalmol 91:1323-6. 2007
    ..The efficacy and safety of repeated injections of intravitreal triamcinolone (IVTA) for diabetic macular oedema is unclear, with results of previous reports conflicting...
  8. ncbi Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial
    Mark C Gillies
    Save Sight Institute, Department of Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, Australia
    Ophthalmology 113:1533-8. 2006
    ..To report 2-year safety and efficacy outcomes from a trial of intravitreal triamcinolone acetonide (TA) injections (4 mg) in eyes with diabetic macular edema and impaired vision that persisted or recurred after laser treatment...
  9. ncbi Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract
    Mark C Gillies
    Save Sight and Eye Health Institute, University of Sydney, NSW, Australia
    Ophthalmology 112:139-43. 2005
    ..To investigate the association between elevated intraocular pressure (IOP) and accelerated cataract formation in patients treated with intravitreal triamcinolone...
  10. ncbi Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial
    Mark C Gillies
    Save Sight Institute, The University of Sydney, Sydney, Australia
    Ophthalmology 118:866-72. 2011
    ..To report the 24 months outcomes from a clinical trial of intravitreal triamcinolone acetonide (IVTA) plus laser versus laser treatment only in eyes with diabetic macular edema (DME)...
  11. ncbi Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial
    Mark C Gillies
    Department of Clinical Ophthalmology, School of Public Health, and Sydney Eye Hospital, University of Sydney, Sydney, New South Wales, Australia
    Arch Ophthalmol 122:336-40. 2004
    ..To determine the safety of a single intravitreal injection of triamcinolone acetonide (4 mg) in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration...
  12. ncbi A randomized phase II trial of interferon-alpha2b versus 5-fluorouracil after trabeculectomy
    M C Gillies
    Department of Ophthalmology, University of Sydney, New South Wales, Australia
    Aust N Z J Ophthalmol 27:37-44. 1999
    ..of the present study was to investigate the safety and potential efficacy of subconjunctival interferon-alpha2b (IFN-alpha), either alone or in combination with 5-fluorouracil (5-FU), in reducing the risk of failure of glaucoma surgery..
  13. ncbi A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results
    Mark C Gillies
    Save Sight and Eye Health Institute, and the Department of Clinical Ophthalmology, University of Sydney, New South Wales, Australia
    Arch Ophthalmol 121:667-73. 2003
    ..To determine if a single intravitreal injection of 4 mg of triamcinolone acetonide in patients with classic choroidal neovascularization associated with age-related macular degeneration can safely reduce the risk of severe visual loss...
  14. ncbi Regulators of vascular permeability: potential sites for intervention in the treatment of macular edema
    M C Gillies
    Save Sight Institute, Sydney University, Australia
    Doc Ophthalmol 97:251-60. 1999
    ..The further elucidation of these processes may be useful in the development of better treatments for breakdown of the inner blood-retinal barrier...
  15. ncbi Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration
    P L Penfold
    Department of Clinical Ophthalmology, University of Sydney, Sydney, Australia
    Clin Exp Immunol 121:458-65. 2000
    ..The results further indicate that TA has the potential to influence cellular permeability, including the barrier function of the retinal pigment epithelium (RPE) in AMD-affected retinae...
  16. ncbi Conditioned medium from mixed retinal pigmented epithelium and Müller cell cultures reduces in vitro permeability of retinal vascular endothelial cells
    M Tretiach
    Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney 2001, Australia
    Br J Ophthalmol 88:957-61. 2004
    ..To investigate the in vitro effect of laser photocoagulation on blood-retinal barrier permeability...
  17. ncbi Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration
    S Cherepanoff
    Anatomical Pathology, SEALS, Prince of Wales Hospital, Level 4, Campus Centre, Randwick, NSW, Australia
    Br J Ophthalmol 94:918-25. 2010
    ..To determine the sub-macular Bruch's membrane (BrM) macrophage count and the choroidal and BrM macrophage immunophenotype in normal eyes and in eyes with early and advanced age-related macular degeneration (AMD)...
  18. ncbi Immunological and aetiological aspects of macular degeneration
    P L Penfold
    Department Clinical Ophthalmology, Save Sight Institute, University of Sydney, NSW 2006, Australia
    Prog Retin Eye Res 20:385-414. 2001
    ....
  19. ncbi Pseudo-endophthalmitis after intravitreal injection of triamcinolone
    F K P Sutter
    Save Sight Institute, Department of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, Australia
    Br J Ophthalmol 87:972-4. 2003
    ..To describe an unusual endophthalmitis-like reaction after an intravitreal injection of triamcinolone acetonide in four patients...